Morbidity and Mortality of Acute Renal Failure in COVID-19 Patients in Intensive Care According to Waves/Variant: Case of the Grand Hôpital de l’Est Francilien Site de Meaux
Introduction: The incidence of acute renal failure (ARF) varies between 20% and 40% of cases for COVID-19 patients admitted to the intensive care unit, with very high mortality, but heterogeneous according to the different epidemic waves, probably due to the genetic variant phenomenon of the virus. The aim of this study is to determine the morbidity and mortality of COVID-19 patients admitted with ARF to the intensive care unit of the Grand H?pital Est Francilien (GHEF) according to the waves and variants. Methods: Cross-sectional observational study of COVID-19 patients with ARF admitted to the intensive care unit of the GHEF site in Meaux covering the period from March 1st 2020 to December, 31st 2021. Per-hospitalisation and outcome data were collected and analysed with SPSS version 25.0 software using the Chi-square or Fischer’s exact test or Student’s t-test and logistic regression for p < 0.05. Results: A total of 86 patients were included. The mean age was higher (70 ± 8.5) in patients in the fourth wave than in the other waves (p = 0.015), with male predominance in all waves without significant difference. Co-morbidities: hypertension, diabetes, heart disease, dyslipidaemia and arrhythmia complete with fibrillation were present in all waves. The majority of patients were classified as KDIGO 1 for the different waves (1st: 61.9%, 2nd: 86.5%, 3rd: 80%, and 4th: 75%), with the same trend according to variant (alpha: 80%, beta: 75%, delta: 81.3%, omicron: 75%). Mortality by the wave was: 1st: 28.5%, 2nd: 37.5%, 3rd: 23% and 4th: 11%) and by variant: alpha: 24.2%, beta: 44.8%, delta: 20.7%, omicron: 10.3%). Overall mortality was 33.7%. Case fatality was higher in the fourth wave. Hypertension, shock, failure to recover renal function, acute lung oedema, ventilator-associated lung disease and hyperkalaemia were factors associated with mortality (p < 0.001). Conclusion: Acute renal failure is common in COVID-19 patients admitted to the intensive care unit, and mortality is not negligible. The beta variants and the second wave presented more cases of renal impairment, although the mechanism is still unknown. Further studies are needed to understand this mechanism and perhaps to be able to identify the cause.
References
[1]
Martinez-Rojas, M.A., Vega-Vega, O. and Bobadilla, N.A. (2020) Le rein est-il une cible du SRAS-CoV-2? American Journal of Physiology-Renal Physiology, 318, F1454-F1462. https://doi.org/10.1152/ajprenal.00160.2020
[2]
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X. and Zhang, J. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323, 1061-1069. https://doi.org/10.1001/jama.2020.1585
[3]
Gupta, S., Coca, S.G. and Chan, L. (2020) AKI Treated with Renal Replacement Therapy in Critically Ill Patients Covid-19. Journal of the American Society of Nephrology, 32, 161-176. https://doi.org/10.1681/ASN.2020060897
[4]
Hoffman, M., Kleine-Weber, H. and Schroeder, S. (2020) ARS-Cov-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181, 271-280. https://doi.org/10.1016/j.cell.2020.02.052
[5]
Mizuiri, S. and Ohashi, Y. (2015) ACE and ACE2 in Kidney Disease. World Journal of Nephrology, 4, 74-82. https://doi.org/10.5527/wjn.v4.i1.74
[6]
Hirsch, J.S., Ng, J.H., Ross, D.W., Sharma, P., Shah, H.H., Barnett, R.L., et al. (2020) Acute Kidney Injury in Patients Hospitalized with Covid-19. Kidney International, 98, 209-218. https://doi.org/10.1016/j.kint.2020.05.006
[7]
Gabarre, P., Dumas, G. and Zafrani, L. (2021) Insuffisance rénale aiguë chez les patients COVID-19 en soins intensifs. Médecine Intensive Réanimation, 30, 43–52. https://doi.org/10.37051/mir-00069
[8]
Cao, M., Zhang, D., Wang, Y., et al. (2020) Clinical Features of Patients Infected with the 2019 Novel Coronavirus (Covid-19) in Shanghai, China. https://doi.org/10.1101/2020.03.04.20030395
[9]
Delma, S., Akodmo, S.I., Bonzi, Y.J., Zochinga, P., Traore, S.H., Sanogo, S.E., et al. (2021) L’insuffisance rénale aigue au cours de la Covid-19 au Burkina Faso: Prévalence et facteurs associés. Néphrologie & Thérapeutique, 17, 383. https://doi.org/10.1016/j.nephro.2021.07.084
[10]
Karray, R., Jamoussi, A., Ayed, S., Lakhdhar, D., Rachdi, E., Ben Khelil, J., et al. (2020) Surmortalité de l’insuffisance rénale aiguë oligoanurique au cours de la COVID-19: étude prospective tunisienne. Néphrologie & Thérapeutique, 16, 312. https://doi.org/10.1016/j.nephro.2020.07.170
[11]
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z. and Dong, L. (2020) Kidney Disease Is Associated with in Hospital Death of Patients with COVID-19. Kidney International, 97, 829-838. https://doi.org/10.1016/j.kint.2020.03.005
[12]
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J. and Liu, H. (2020) Clinically Course and Outcomes of Critically Ill Patients with SARS-Cov-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective Observational Study. The Lancet Respiratory Medicine, 8, 475-481. https://doi.org/10.1016/S2213-2600(20)30079-5
[13]
Grasseli, G., Zangrillo, A., et al. (2021) Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV2 Admitted to ICUs of the Lombardy Region, Italy. JAMA, 323, 1574-1581. https://doi.org/10.1001/jama.2020.5394
[14]
Suleyman, G., Fadel, R.A., Malette, K.M., et al. (2020) Clinical Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Network Open, 3, e2012270. https://doi.org/10.1001/jamanetworkopen.2020.12270
[15]
Nlandu, Y., et al. (2021) Predictors of Mortality in Covid-19 Patients at Kinshasa Medical Center and a Survival Analysis: Retrospective Cohort Study. BMC Infectious Diseases, 21, Article No. 1272. https://doi.org/10.1186/s12879-021-06984-x https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06984-x
[16]
Khalil, M., Mehdi, R., et al. (2023) Analyse de survie de la durée du séjour des patients ateints de la Covid-19 dans la province d’Ilam, en Iran. Journal of Clinical Medicine, 12, Article 6678. https://doi.org/10.3390/jcm12206678
[17]
Murrel, D.F. and Murase, J.E. (2020) The Potential Protectrice Effect of Estrogen: A Plausible Theory for Why COVID-19 Mortality Is Lower in Females. International Journal of Women’s Dermatology, 6, 152-153. https://doi.org/10.1016/j.ijwd.2020.04.011
[18]
Xia, P., Wen, Y., Duan, Y., et al. (2020) Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort. Journal of the American Society of Nephrology, 8, 475-481. https://doi.org/10.1681/ASN.2020040426
[19]
Rubin, S., Orieux, A., Prevel, R., et al. (2020) Characterization of Acute Kidney Injury in Critically Ill Patients with Severe Coronavirus Disease 2019. Clinical Kidney Journal, 13, 354-361. https://doi.org/10.1093/ckj/sfaa099
[20]
Chan, L., Chaudhary, K., Saha, A., et al. (2020) AKI in Hospitalized Patients with COVID-19. Journal of the American Society of Nephrology, 32, 151-160. https://doi.org/10.1681/ASN.2020050615
[21]
Makulo, J.R., Manzambi, B.M., Nlandu, Y.M., Mandina, M.N., Kutoloka, C.M., et al. (2020) Surveillance des décès aux Cliniques Universitaires de Kinshasa (RDC): La COVID-19 a-t-elle entraîné une surmortalité? Annales Africaines de Médecine, 14, 3923-3929.
